Indeed, restoring Pax5 through Tet-Off the transgenic shPax5 in a mouse B-ALL model (driven by Pax5 knockdown and constitutively active Stat5) enables differentiation and immunophenotypic maturation by reshaping the B cell development program, leading to durable disease remission (82). The gene discussed is PAX5; the disease is acute lymphoblastic leukemia.